Precipio, Inc. (PRPO) vs T2 Biosystems, Inc. (TTOO)

Precipio, Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. Precipio, Inc. is the larger, with a market value of $33.3M against $6.5M — 5.1× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against −30.2%. Precipio, Inc. has the higher net margin (−4.47% vs −559.5%) and the lower return on invested capital (−7.63% vs 0.00%). Across the 16 metrics below, Precipio, Inc. leads on 11 and T2 Biosystems, Inc. on 5.

Valuation

Metric PRPO TTOO Diagnostics & Research median
P/E n/m n/m 34.52
P/S 1.25 n/m 4.24
P/B 2.30 n/m 3.42
Price to free cash flow 43.09 n/m 33.51
EV/EBITDA 107.75 n/m 23.44
EV/Sales 1.17 6.26 5.18
Earnings yield (3.36%) 0.00% (1.50%)
Free cash flow yield 2.32% 0.00% 0.00%

Profitability

Metric PRPO TTOO Diagnostics & Research median
Gross margin 44.11% (76.76%) 48.32%
Operating margin (5.68%) (542.59%) (5.68%)
Net margin (4.47%) (559.52%) (4.10%)
Free cash flow margin 2.90% (476.64%) 0.00%
Return on equity (8.98%) 277.61% 0.00%
Return on assets (6.05%) (140.00%) (6.05%)
Return on invested capital (7.63%) 0.00% 0.00%

Growth

Metric PRPO TTOO Diagnostics & Research median
Revenue growth (TTM) 28.04% (30.19%) 8.99%
EPS growth (last fiscal year) 92.15% 98.44% 20.36%
Revenue growth, 5-year CAGR 31.60% (7.29%) 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRPO TTOO Diagnostics & Research median
Debt to equity 0.07 0.00 0.01
Current ratio 1.77 0.40 2.27
Net debt to EBITDA (3.30) 0.32 0.68

Dividend

Metric PRPO TTOO Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric PRPO TTOO Diagnostics & Research median
Market cap 33.28m 6.48m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack